This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Activated Leukocyte Cell Adhesion Molecule (ALCAM)
Product Overview
BioVenic's Recombinant Canine Activated Leukocyte Cell Adhesion Molecule (ALCAM) is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 31.2 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL). It can be used as a positive control or as an immunogen.
Specifications
Target Information
Activated leukocyte cell adhesion molecule is encoded by the ALCAM gene in dogs. ALCAM is a member of the immunoglobulin superfamily and belongs to a recent subgroup with five extracellular immunoglobulin-like domains.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in PBS or other buffer. Aliquote the reconstituted solution to minimise freeze-thaw cycles.